Charlée Nardin

1.4k citations

55 papers · 584 indexed · h-index 12

Impact in

Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Dermatology 12
Oncology 27
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 11
- Cutaneous Melanoma Detection and Management 9

Co-authors: F. Aubin Carmen Garrido Jessica Gobbo Gaëtan Chanteloup Marine Cordonnier Laurent Arnould Marie‐Paule Algros Valentin Dérangère
Journals: Journal of Clinical Oncology (6 papers)European Journal of Cancer (4 papers)Melanoma Research (4 papers)Acta Dermato Venereologica (4 papers)European Journal of Dermatology (3 papers)
Partner nations: France United States South Korea

In The Last Decade

Charlée Nardin

46 papers receiving 577 citations

Peers

Countries citing papers authored by Charlée Nardin

Since Specialization

Citations

This map shows the geographic impact of Charlée Nardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlée Nardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlée Nardin more than expected).

Fields of papers citing papers by Charlée Nardin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlée Nardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlée Nardin. The network helps show where Charlée Nardin may publish in the future.

Co-authors

The 25 scholars most cited alongside Charlée Nardin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charlée Nardin Line = papers co-authored together Charlée Nardin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune checkpoint inhibitors use in lung transplant recipients: a case series and systematic review of literature ESMO Open ·N Mahmoud, G. Pamart, Charlée Nardin, Arthur Schüller, Sandrine Hirschi, T. Dégot, Pierre‐Emmanuel Falcoz, Anne Olland, Charles Tacquard, Romain Kessler, Benjamin Coiffard, B. Renaud-Picard	2025	0
2	Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma Melanoma Research ·Aymeric Hennemann, E. Puzenat, Marion Decreuse, Fabrice Vuillier, Charlée Nardin, F. Aubin	2024	0
3	Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL). Journal of Clinical Oncology ·Charlée Nardin, C. Cavalieri, Célèste Lebbé, Cécile Pagès, E. Gérard, Jacques Rouanet, Claudia Luisa Bejar Ardiles, N. Kramkimel, C. Lesage, Florent Grange, B. Bonniaud, S. Darras, Yannick Le Corre, Philippe Saïag, F. Brunet‐Possenti, M. Saint‐Jean, Henri Montaudié, M. Amini Adle, Elisa Funck‐Brentano, F. Aubin, (unknown)	2024	0
4	Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study British Journal of Dermatology ·Karima Hammas, Charlée Nardin, Séverine Boyer, Catherine Michel, F. Aubin, Anne‐Sophie Woronoff	2024	1
5	Incidence du carcinome basocellulaire en France et tendances entre 1980 et 2019 : étude en population à partir de registres des cancers Karima Hammas, Charlée Nardin, Sylvie Boyer, Cyril J. Michel, F. Aubin, Anne‐Sophie Woronoff	2023	1
6	1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA Annals of Oncology ·E. Gérard, Célèste Lebbé, Émilie Lanoy, G. Quéreux, Philippe Bernard, M-A. Viguier, Nicolás Meyer, Laurent Mortier, M. Dinulescu, Délphine Legoupil, Eve‐Marie Neidhardt, Philippe Saïag, S. Trabelsi-Messai, P. Celérier, Charlée Nardin, E. Maubec, E. Wierzbicka, Stéphanie Perrier, S. Garnier, Caroline Robert	2023	3
7	Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients Cancers ·Constance Reichert, Capucine Baldini, Sarah Mezghani, E. Maubec, Christine Longvert, Laurent Mortier, G. Quéreux, A. Jannic, L. Machet, Julie De Quatrebarbes, Charlée Nardin, N. Bénéton, M. Amini Adle, Elisa Funck‐Brentano, Vincent Descamps, Lorry Hachon, Nausicaa Malissen, Barouyr Baroudjian, F. Brunet‐Possenti	2023	3
8	Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients’ Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC) Cancers ·Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, Elisa Funck‐Brentano, E. Puzenat, Valentine Heidelberger, G. Jeudy, M. Samimi, C. Lesage, Lise Boussemart, L. Peuvrel, Jacques Rouanet, F. Brunet‐Possenti, E. Gérard, Alice Seris, Thomas Jouary, M. Saint‐Jean, Marc Puyraveau, Philippe Saïag, F. Aubin	2023	12
9	Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study Journal of the European Academy of Dermatology and Venereology ·M. Beylot‐Barry, G. Quéreux, Charlée Nardin, A.‐B. Duval‐Modeste, O. Dereure, S. Dalac‐Rat, Gábor Dobos, Anne Pham‐Ledard, C. Ram‐Wolff, M. D'Incan, Florent Grange, Viorica Braniste, M. Bagot	2023	13
10	An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases European Journal of Cancer ·Caroline Dutriaux, Caroline Robert, Jean‐Jacques Grob, Laurent Mortier, O. Dereure, Célèste Lebbé, Sandrine Mansard, Florent Grange, Eve‐Marie Neidhardt, Thierry Lesimple, L. Machet, Christophe Bédane, H. Maillard, S. Dalac‐Rat, Charlée Nardin, A. Szenik, A. Denden, Philippe Saïag	2022	8
11	Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma Journal of Investigative Dermatology ·Charlée Nardin, Caroline Laheurte, E. Puzenat, Laura Boullerot, Mélanie Ramseyer, Amélie Marguier, Marion Jacquin, Yann Godet, F. Aubin, Olivier Adotévi	2021	13
12	Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients European Journal of Cancer ·Laura Mansi, Laurie Spehner, Étienne Daguindau, Kévin Bouiller, Hamadi Almotlak, Ulrich Stein, Adeline Bouard, Stéfano Kim, Élodie Klajer, Marine Jary, Guillaume Meynard, Angélique Vienot, Charlée Nardin, Fernando Bazán, Quentin Lepiller, Virginie Westeel, Olivier Adotévi, Christophe Borg, Marie Kroemer	2021	17
13	A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience – Franche Comté, France European Journal of Dermatology ·Irène Gallais-Serezal, E. Puzenat, Joséphine Moreau, F. Dresco, F. Pelletier, Charlée Nardin, F. Aubin	2021	1
14	Increase in American Joint Committee on Cancer Stage at Diagnosis for Patients with Skin Cancers after the COVID-19 Lockdown Acta Dermato Venereologica ·Charlée Nardin, Lise Senot, Paul Pernot, E. Puzenat, F. Aubin, Lucas Morin	2021	1
15	Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib European Journal of Cancer ·Philippe Saïag, Caroline Robert, Jean‐Jacques Grob, Laurent Mortier, O. Dereure, Célèste Lebbé, Sandrine Mansard, Florent Grange, Eve‐Marie Neidhardt, Thierry Lesimple, L. Machet, Christophe Bédane, H. Maillard, S. Dalac‐Rat, Charlée Nardin, A. Szenik, A. Denden, Caroline Dutriaux	2021	10
16	Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort Journal of the American Academy of Dermatology ·Clémentine Carlet, Stéphane Dalle, M.‐T. Leccia, Laurent Mortier, S. Dalac‐Rat, Caroline Dutriaux, Délphine Legoupil, Henri Montaudié, O. Dereure, Julie De Quatrebarbes, F. Granel‐Brocard, Myrtille Le-Bouar, J. Charles, F. Brunet‐Possenti, Brigitte Dréno, Wendy Lefevre, Clara Allayous, Célèste Lebbé, Charlée Nardin	2021	8
17	Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study Dermatology Research and Practice ·Clémentine Carlet, D. Bichard, M.‐A. Richard, E. Mahé, Clémence Saillard, E. Brenaut, A. Dupuy, L. Misery, A. Villani, D. Jullien, E. Puzenat, Charlée Nardin, F. Aubin, (unknown)	2020	2
18	Mastite granulomateuse idiopathique associée à un érythème noueux Annales de Dermatologie et de Vénéréologie ·C. Jacquin-Porretaz, Christine Devalland, T. Delapparent, Charlée Nardin, A.-S. Dupond	2019	11
19	Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH Science Signaling ·Dalee Zhou, Koji Ota, Charlée Nardin, Michelle Feldman, Adam J. Widman, Olivia Wind, Amanda Simon, Michael Reilly, Lonny R. Levin, Jochen Buck, Kazumasa Wakamatsu, Shosuke Ito, Jonathan H. Zippin	2018	31
20	Efficiency of an mTOR Inhibitor in Kasabach-Merritt Phenomenon with Indolent Tufted Angioma: A Case Report Acta Dermato Venereologica ·Charlée Nardin, O. Boccara, C. Eschard, M. Bayaram, Thibaud Dabudyk, F. Aubin, E. Puzenat	2016	1

About Charlée Nardin

Charlée Nardin is a scholar working on Dermatology, Oncology, Immunology, Transplantation and Epidemiology, having authored 55 papers that have together received 584 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (11 papers), Cutaneous Melanoma Detection and Management (9 papers), Immunotherapy and Immune Responses (8 papers), Brain Metastases and Treatment (5 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Immunology (198 citations), Oncology (245 citations), Dermatology (72 citations), Cancer Research (78 citations) and Molecular Biology (296 citations). Charlée Nardin has collaborated with scholars based in France, United States and South Korea. Frequent co-authors include F. Aubin, Carmen Garrido, Jessica Gobbo, Gaëtan Chanteloup, Marine Cordonnier, Laurent Arnould, Marie‐Paule Algros, Valentin Dérangère, E. Puzenat and Olivier Adotévi. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Melanoma Research, Acta Dermato Venereologica and European Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact